Search clinical trials for: MK-1006 FCT

Total 9170 results

Merck Sharp & Dohme LLC

Completed

A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)

Type 2 Diabetes
Merck Sharp & Dohme LLC

Completed

MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)

Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC

Terminated

A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

Type 2 Diabetes
Merck Sharp & Dohme LLC

Recruiting

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Follicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Richter Transformation Lymphoma

Poland, United States, Canada, Chile, China, Estonia, Israel, Italy, Korea, Republic of, Spain, Sweden, Turkey, Czechia, Germany, Brazil, Portugal, Ireland, Singapore, United Kingdom, Japan, Peru
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)

Asthma
Merck Sharp & Dohme LLC

Active, not recruiting

A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Mature B-cell Neoplasms

Japan
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Non-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms Macroglobulinaemia

Poland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Hematological Malignancies

China
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis

Severe Acute Pancreatitis

Spain
Sichuan Academy of Medical Sciences
Peking Union Medical College Hospital

Completed

Early Enteral Nutrition for Severe Acute Pancreatitis

Acute Necrotizing Pancreatitis

China
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Healthy Subjects

Netherlands
Shire

Completed

FST-100 in the Treatment of Acute Viral Conjunctivitis

Acute Viral Conjunctivitis

United States, Brazil
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)

Overactive Bladder
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
Merck Sharp & Dohme LLC

Completed

A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

Type 2 Diabetes Mellitus
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
Wei Zhou

Unknown

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

Liver Tumor | Gastric Tumor | Pancreatic Tumor

China
University of British Columbia
Mitacs

Completed

Cognitive Brain Training in Older Adults

Mild Cognitive Impairment

Canada
Idorsia Pharmaceuticals Ltd.

Completed

Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239

Healthy

Portugal
Medical College of Wisconsin

Recruiting

Conditional Cash Transfer Intervention to Improve T2DM (DMCT)

Type 2 Diabetes

United States
Afferent Pharmaceuticals, Inc.

Completed

Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)

Refractory Chronic Cough
University of Coimbra

Completed

Low Intensity Internet Therapy for Chronic Illness (@LIIT.CI)

Chronic Medical Conditions

Portugal
VA Office of Research and Development
VA Palo Alto Health Care System

Active, not recruiting

Thriving in the Midst of Moral Pain: The Acceptability and Feasibility of Acceptance and Commitment Therapy for Moral Injury (ACT-MI) Among Warzone Veterans

Moral Injury

United States
Bio-Cancer Treatment International Limited

Unknown

Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

Hong Kong
Uppsala University
Örebro University, Sweden; Uppsala University Hospital; Karlstad University

Completed

Psychological Treatment Targeting Acceptance and Compassion in Chronic Pain Patients

Chronic Pain | Self-Criticism

Sweden
Merck Sharp & Dohme LLC

Completed

A Single Rising Dose Study of MK-8150 (MK-8150-001)

Hypertension | Isolated Systolic Hypertension (ISH)
University of Miami
LiteCure LLC

Withdrawn

Laser Therapy for Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathy

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Healthy Subject

China
The Hospital for Sick Children
Labatt Family Heart Centre; Trainee award through Ontario Student Opportunity...

Completed

Dietary Treatment of Infants With Chylothorax

Chylothorax

Canada
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
EuBiologics Co.,Ltd

Completed

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
University of Birmingham

Completed

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) (PARC)

Cancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AML

United Kingdom, Australia, Netherlands
Columbia University
Merck Sharp & Dohme LLC

Terminated

MRI and PET to Assess Pembrolizumab Response (MPAK)

Malignant Melanoma, Metastatic

United States
Oregon Health and Science University

Completed

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

Obesity

United States
Shire

Completed

FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

Acute Adenoviral Conjunctivitis

United States, India
Rutgers, The State University of New Jersey

Recruiting

Refinements of Functional Communication Training

Aggression | Self-injurious Behavior

United States
ArQule, Inc., a subsidiary of Merck Sharp & Dohme...

Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Lymphoma, B-Cell | Follicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Richter's Transformation

United States
B. Braun Medical SA

Terminated

ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients (ICULIP)

Critical Illness

Spain
Idorsia Pharmaceuticals Ltd.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)

Healthy

France
Bio-Cancer Treatment International Limited
Oncotherapeutics

Completed

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

Melanoma | Prostate Adenocarcinoma

United States
Bio-Cancer Treatment International Limited
The University of Hong Kong

Terminated

A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma

Lymphoma | Leukemia

China
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
Veterans Medical Research Foundation

Completed

Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans

Depression | Anxiety | Distress | Postconcussive Symptoms

United States
Kowa Research Institute, Inc.

Completed

Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 (OCT)

Glaucoma | Healthy | Retinal Disease

United States
Federal University of São Paulo

Completed

Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients

HIV Infections | Acquired Immunodeficiency Syndrome

Brazil
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients (EARLY-HEP-C)

Hepatitis C | HIV

Spain
Matthew J O'Brien, PhD, BCBA-D
National Institute of Mental Health (NIMH); Emory University; University of Houston and other collaborators

Completed

Comparing Behavioral Assessments Using Telehealth for Children With Autism

Autism Spectrum Disorder

United States

Search clinical trials for: MK-1006 FCT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations